Operating

Orthobond Secures De Novo Classification Grant for First-in-Class Antibacterial Surface Treatment Applied to a Spinal Device

Retrieved on: 
Monday, April 8, 2024
Medical Supplies, Medical Devices, FDA, Health, Dental, Biotechnology, De novo, Textile, Patient, Corporation, Sterilization, Bacteria, Operating, Infection, Pain, Physician, Food, Sports medicine

Orthobond Corporation , a leader in covalently-bound antibacterial surface technologies with broad applications in the medical device industry, announced today that the U.S. Food and Drug Administration (FDA) granted its De Novo marketing request for the use of Ostaguard™, its proprietary antibacterial surface treatment, on a permanent medical device.

Key Points: 
  • Orthobond Corporation , a leader in covalently-bound antibacterial surface technologies with broad applications in the medical device industry, announced today that the U.S. Food and Drug Administration (FDA) granted its De Novo marketing request for the use of Ostaguard™, its proprietary antibacterial surface treatment, on a permanent medical device.
  • Numerous studies have shown between 70-100% of explanted hardware from failed joint implants have some level of contamination from different sources.
  • Orthobond pioneered a method to covalently-bond its antibacterial molecule to the surface of implants.
  • The proprietary surface technology is applied during the manufacturing process prior to packaging and sterilization.

Clinical Communication & Collaboration Market Worth $4.8 billion | MarketsandMarkets™

Retrieved on: 
Tuesday, April 9, 2024
Hill-Rom, Microsoft, Patient, Conditional sentence, Trauma, TigerConnect, Big data, Investment, Patient safety, NEC, Jive Software, Automation, Partnership, Stryker Corporation, Software, Cisco, Baxter International, Safety, OPN, Privacy, Health, Advantage, Communication, Knowledge, Hospital, Research, Growth, Market development, UC, OCI, Operating, EHR, Physician, Nursing

Based on application, the Clinical Communication and Collaboration market is segmented into lab & radiology communication, nurse communication, patient communication & emergency alerts, physician communication.

Key Points: 
  • Based on application, the Clinical Communication and Collaboration market is segmented into lab & radiology communication, nurse communication, patient communication & emergency alerts, physician communication.
  • Moreover, the unique communication needs of physicians, including the requirement for secure and confidential communication channels, further highlights the importance of dedicated physician communication solutions within the clinical communication and collaboration market.
  • Clinical Communication & Collaboration Market Dynamics:
    Key Market Players of Clinical Communication & Collaboration Industry:
    Prominent players in the Clinical Communication and Collaboration market include Avaya LLC (US), Oracle (US), Cisco Systems, Inc. (US), Microsoft Corporation (US), Baxter International (Hillrom) (US), symplr (US), NEC Corporation (Japan), Spok Inc. (US), Vocera Communications (Stryker) (US), Ascom Holding AG (Switzerland), Everbridge (US), Hidden Brains InfoTech.
  • Market Diversification: Exhaustive information about the software portfolios, growing geographies, recent developments, investments in the Clinical Communication and Collaboration market.

Clinical Communication & Collaboration Market Worth $4.8 billion | MarketsandMarkets™

Retrieved on: 
Tuesday, April 9, 2024
Hill-Rom, Microsoft, Patient, Conditional sentence, Trauma, TigerConnect, Big data, Investment, Patient safety, NEC, Jive Software, Automation, Partnership, Stryker Corporation, Software, Cisco, Baxter International, Safety, OPN, Privacy, Health, Advantage, Communication, Knowledge, Hospital, Research, Growth, Market development, UC, OCI, Operating, EHR, Physician, Nursing

Based on application, the Clinical Communication and Collaboration market is segmented into lab & radiology communication, nurse communication, patient communication & emergency alerts, physician communication.

Key Points: 
  • Based on application, the Clinical Communication and Collaboration market is segmented into lab & radiology communication, nurse communication, patient communication & emergency alerts, physician communication.
  • Moreover, the unique communication needs of physicians, including the requirement for secure and confidential communication channels, further highlights the importance of dedicated physician communication solutions within the clinical communication and collaboration market.
  • Clinical Communication & Collaboration Market Dynamics:
    Key Market Players of Clinical Communication & Collaboration Industry:
    Prominent players in the Clinical Communication and Collaboration market include Avaya LLC (US), Oracle (US), Cisco Systems, Inc. (US), Microsoft Corporation (US), Baxter International (Hillrom) (US), symplr (US), NEC Corporation (Japan), Spok Inc. (US), Vocera Communications (Stryker) (US), Ascom Holding AG (Switzerland), Everbridge (US), Hidden Brains InfoTech.
  • Market Diversification: Exhaustive information about the software portfolios, growing geographies, recent developments, investments in the Clinical Communication and Collaboration market.

Hoag Announces $25 Million Gift to Boldly Hoag Campaign

Retrieved on: 
Monday, April 8, 2024
Health, Pacific Life, Prostate cancer, Bed, Environment, Patient, Cancer, Benjamin, Operating, Wood, Architecture, Heart, Hoag (health network), Hospital

IRVINE, Calif., April 8, 2024 /PRNewswire/ -- Scheduled to open in 2026, Hoag's reimagined Sun Family Campus in Irvine will be built around the Du Family Hospital Pavilion in honor of a generous $25 million gift from longtime philanthropists Ben and Carmela Du.

Key Points: 
  • Their first major gift to Hoag in 2015 established the Benjamin & Carmela Du Endowed Chair in Urologic Oncology, which continues to support breakthroughs in prostate cancer treatment at Hoag.
  • Ben and Carmela are also members of Hoag Innovators, a group of community leaders dedicated to catalyzing innovation at Hoag through the power of collective giving.
  • The Du family joins Diana and David Sun, the Pacific Life Foundation, and other visionary donors in Hoag's philanthropic community fueling a greater, more empowered health care future for all through the Hoag Hospital Foundation's ambitious $300 million Boldly Hoag campaign.
  • With more than $180 million raised toward the project, the Boldly Hoag campaign is about more than new buildings; it's about redefining what comes next for Hoag patients, staff, the community, and health care more broadly.

Gastro Care Partners Expands into Phoenix, Arizona Through Partnership with Reddy GI Associates

Retrieved on: 
Tuesday, March 12, 2024
Radiology, General Health, Health, Other Health, Diagnosis, Internal medicine, GCP, Empathy, Patient, Hospital, MD, Quality of life, Operating, EGD, Hepatology, Gastroenterology

Gastro Care Partners (“GCP”), one of the largest providers of gastroenterology services and ancillary patient treatment services in Colorado and Wyoming, today announced that Reddy GI Associates (“Reddy GI”) has joined the GCP family of practices.

Key Points: 
  • Gastro Care Partners (“GCP”), one of the largest providers of gastroenterology services and ancillary patient treatment services in Colorado and Wyoming, today announced that Reddy GI Associates (“Reddy GI”) has joined the GCP family of practices.
  • Reddy GI was founded in 2009 by Sudhakar Reddy, MD, a board-certified physician in gastroenterology, anatomic pathology, clinical pathology, and internal medicine, with the goal of improving digestive health, reducing stress, and providing the tools needed to optimize quality of life for its patient population.
  • We very much look forward to joining forces with GCP and working alongside them to continue growing our practice and serving the Phoenix community for years to come,” added Dr. Reddy.
  • GCP is backed by Varsity Healthcare Partners, a middle-market healthcare services investment firm with expertise in growing care provider platforms.

Highmark Health, AHN Announce Plans to Transform Allegheny General Hospital Campus

Retrieved on: 
Thursday, April 4, 2024
Magnet, Temperature, Conference, Health, Growth, Bed, Transplant, Caregiver, Patient, Allegheny Health Network, Allegheny General Hospital, AHN, City, Research, Trauma, IMP, Electrophysiology, MD, Operating, AGH, Investment, System, Hospital, Heart, CVI, Safety, Lighting, Nuclear medicine, DSM-IV codes, Nursing

PITTSBURGH, April 4, 2024 /PRNewswire-PRWeb/ -- Highmark Health and Allegheny Health Network (AHN) officials today reinforced a commitment to their Living Health model by announcing plans for continued significant investments in the network. Specifically, Allegheny General Hospital (AGH), AHN's flagship academic medical center, will be transformed with a new cardiovascular tower and emergency department, among other upgrades, further advancing and modernizing the hospital's care delivery and technological capabilities.

Key Points: 
  • PITTSBURGH, April 4, 2024 /PRNewswire-PRWeb/ -- Highmark Health and Allegheny Health Network (AHN) officials today reinforced a commitment to their Living Health model by announcing plans for continued significant investments in the network.
  • "Creating high-quality patient experiences and outcomes, and equitable access, through personalized care models designed to promote wellness and address health needs, is our goal at AHN.
  • The centerpiece of the AGH campus transformation is construction of a new patient tower which will house the nationally recognized services of the AHN Cardiovascular Institute (CVI).
  • One such project already underway at the hospital is the creation of a new hub for the AHN Neuroscience Institute.

FDA Grants HemoSonics Expanded Use of its Critical Bleeding Management System with Special 510(k) Clearance

Retrieved on: 
Wednesday, April 3, 2024
Patient, Trauma, Hospital, Acquisition, Coagulopathy, Cartridge, Operating, Hemostasis, American Red Cross, Bleeding, Intensive care medicine, FDA, Liver, Journal of Cardiothoracic Surgery, Food, Medical device

DURHAM, N.C., April 3, 2024 /PRNewswire/ -- HemoSonics, a medical device company focused on acute bleeding management, today announced it has received Special 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the expanded use of arterial blood samples with its Quantra QStat® Cartridge. HemoSonics' QStat Cartridge used with the Quantra Hemostasis Analyzer first received 510(k) clearance from the U.S. FDA in 2022 for use in venous whole blood samples. Today's announcement enables hospitals to further standardize and operationalize viscoelastic testing with an arterial and venous indication for both HemoSonics' QStat Cartridge and the QPlus® Cartridge.

Key Points: 
  • HemoSonics' Quantra® Hemostasis Analyzer provides comprehensive blood analysis that details critical bleeding disorders and helps clinicians manage patients back into hemostasis.
  • DURHAM, N.C., April 3, 2024 /PRNewswire/ -- HemoSonics , a medical device company focused on acute bleeding management, today announced it has received Special 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the expanded use of arterial blood samples with its Quantra QStat® Cartridge.
  • HemoSonics' QStat Cartridge used with the Quantra Hemostasis Analyzer first received 510(k) clearance from the U.S. FDA in 2022 for use in venous whole blood samples.
  • "The Quantra System now has the broadest range of FDA-cleared clinical indications of any cartridge-based viscoelastic testing system.

Top NYC Female Plastic Surgeon Dr. Aviva Preminger Expands Practice with Two New State-of-the-Art Operating Rooms in Her Upper East Side NYC Office

Retrieved on: 
Thursday, March 28, 2024
Face, Weill Cornell Medicine, Patient, Operating, Suite, Patient satisfaction, Harvard University, Safety, Multimedia, Health, Breast augmentation, Accreditation, Hedera, Nursing

NEW YORK, March 28, 2024 /PRNewswire-PRWeb/ -- Dr. Aviva Preminger, a leading expert in plastic surgery renowned for her exceptional technique that produces the most natural-looking results, is thrilled to announce the unveiling of two brand new Quad A Approved operating rooms at her Upper East Side office located at 969 Park Ave, Suite 1E/F, New York, NY 10028. This expansion marks a significant milestone for Dr. Preminger's practice and reaffirms her commitment to providing patients with the highest standard of care in the most advanced facilities available.

Key Points: 
  • Known for her expertise and dedication to patient satisfaction, Dr. Aviva Preminger's practice specializes in cosmetic procedures that enhance natural beauty and restore confidence.
  • With the addition of two state-of-the-art operating rooms, Dr. Preminger can now offer her patients an even wider range of surgical options in a cutting-edge, accredited environment.
  • "At Dr. Aviva Preminger's practice, our priority is to help patients achieve their aesthetic goals with precision and compassion," said Dr. Preminger.
  • Situated in the prestigious Upper East Side neighborhood, Dr. Aviva Preminger's office at 969 Park Ave offers patients a convenient and luxurious setting for their cosmetic surgery experience.

HemoSonics Named to Fast Company's 2024 World's Most Innovative Companies List

Retrieved on: 
Thursday, March 21, 2024
Organization, Blood transfusion, Novartis, Patient, Hospital, AI, Hope, Bristol Myers Squibb, Operating, Cartridge, Intensive care medicine, Amgen, Blood, FDA, Medicine, Pharmaceutical industry

DURHAM, N.C. , March 21, 2024 /PRNewswire/ -- HemoSonics, a medical device company focused on acute bleeding management, today announced it has been named to the prestigious list of Fast Company's Most Innovative Companies for 2024. The annual Fast Company flagship awards spotlight companies at the forefront of their respective industries and recognize organizations and products that are transforming industries through their innovations, setting new standards, and achieving remarkable milestones that are moving the world forward. HemoSonics joins previous Fast Company Most Innovative Company winners, including Abbott, Bristol Myers Squib, Novartis, Amgen, Scopio Labs and others.

Key Points: 
  • HemoSonics joins previous Fast Company Most Innovative Company winners, including Abbott, Bristol Myers Squib, Novartis, Amgen, Scopio Labs and others.
  • The World's Most Innovative Companies is Fast Company's hallmark franchise and one of the year's most anticipated awards for groundbreaking innovations.
  • Fast Company's editorial team identified the 2024 Most Innovative Companies driving progress worldwide and across industries, evaluating thousands of submissions through a competitive application process.
  • We face daunting challenges on many fronts, but the solutions we celebrate in Most Innovative Companies give me plenty of hope about the future."

TriasMD Acquires Thousand Oaks Surgery Center to Expand Model in Greater Los Angeles

Retrieved on: 
Thursday, March 21, 2024
Thousand Oaks, California, AAAHC, Partnership, Patient, DISC, Acquisition, Operating, ASC, Spine, Pain management, Elective surgery, Medicare, Podiatry, Physician, Otorhinolaryngology, Hospital

NEWPORT BEACH, Calif., March 21, 2024 /PRNewswire/ -- TriasMD, parent company of the DISC Surgery Centers, has announced its acquisition of Thousand Oaks Surgery Center (map it). This move continues the expansion of DISC's proven data/evidence-driven ambulatory surgery center (ASC) model throughout California and further increases accessibility for patients in Greater Los Angeles. Last year, TriasMD acquired Santa Clarita-based Gateway Surgery Center in February and Walnut Creek-based Pinnacle Surgery Center in October.

Key Points: 
  • NEWPORT BEACH, Calif., March 21, 2024 /PRNewswire/ -- TriasMD , parent company of the DISC Surgery Centers , has announced its acquisition of Thousand Oaks Surgery Center ( map it ).
  • This move continues the expansion of DISC's proven data/evidence-driven ambulatory surgery center (ASC) model throughout California and further increases accessibility for patients in Greater Los Angeles.
  • Last year, TriasMD acquired Santa Clarita-based Gateway Surgery Center in February and Walnut Creek-based Pinnacle Surgery Center in October.
  • Thousand Oaks Surgery Center – to be renamed DISC Surgery Center at Thousand Oaks – is an AAAHC-accredited, Medicare-certified facility featuring four spacious operating rooms, five private pre-op rooms, 11 recovery bays and two luxurious overnight suites for patients staying 23 hours or less.